Actively Recruiting
Study to Assess the Effectiveness and Safety of U101 Oral Capsules in Preventing Recurrent Urinary Tract Infections in Women
Led by TCM Biotech International Corp. · Updated on 2026-10-02
348
Participants Needed
18
Research Sites
4 weeks
Total Duration
AI-Summary
What This Trial Is About
Researchers are evaluating the drug U101 to see if it can prevent recurrent urinary tract infections rUTIs in women aged 20 to under 76 who have a history of these infections. This Phase 3 randomized, double-blind, placebo-controlled trial compares U101 to a placebo to assess its ability to reduce UTI recurrence, improve quality of life, and monitor safety. The study involves women with defined criteria for rUTI history and a negative infection status before starting treatment. Participants will take one capsule of U101 or placebo orally three times a day for the first 8 weeks, then twice a day for the following 16 weeks during the 24-week main study. They will visit the study site every 4 weeks for checkups and tests. Afterward, participants may join an optional 24-week open-label extension OLE where those who had a UTI episode during the main study can receive U101 treatment again or enter long-term safety follow-up without treatment, with visits at Weeks 8 and 24. During the study, participants will report any suspected UTI symptoms for special visits and tests. Researchers will evaluate UTI recurrence, quality of life measures, safety labs, physical exams, and vital signs throughout the main and extension studies. The primary analysis will review the percentage of participants without UTI recurrence after 24 weeks, with ongoing safety monitoring extending 14 days post-treatment. Total participation may last up to 48 weeks including the extension or follow-up periods.
CONDITIONS
Brief Title
Evaluate the Efficacy and Safety of U101 Oral Capsules in the Prevention of Uncomplicated rUTIs in Women
Research Team
E
Emily Ma Clinical Research Manager
P
Principal Investigator
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here